MCMC
PCRX icon

Matrix Capital Management Company’s Pacira BioSciences PCRX Stock Holding History

Matrix Capital Management Company’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-519,703
Closed -$36.8M – 20
2015
Q2 		$36.8M Buy
519,703
+19,703
+4% +$1.55M 1.64% 18
2015
Q1 		$44.4M Buy
500,000
+150,000
+43% +$15.2M 2.28% 17
2014
Q4 		$31M Buy
+350,000
New +$33.1M 1.64% 15

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Matrix Capital Management Company's PCRX Position: Q3 2015 in Review

Matrix Capital Management Company sold out of Pacira BioSciences (PCRX) in Q3 2015, closing a stake of 519,703 shares — an estimated $36.8M sold.

Matrix Capital Management Company first reported a position in PCRX in Q4 2014 and held it in 3 quarters. The position peaked at $44.4M in Q1 2015. 177 funds tracked by Wall St. Rank hold PCRX as of Q3 2015.

  • Matrix Capital Management Company reported no remaining Pacira BioSciences position as of Q3 2015 after selling out during the quarter.
  • Matrix Capital Management Company sold 519,703 Pacira BioSciences shares in Q3 2015, an estimated $36.8M.
  • Matrix Capital Management Company first reported a position in Pacira BioSciences in Q4 2014 and held it in 3 quarters.
  • Matrix Capital Management Company's Pacira BioSciences position peaked at $44.4M in Q1 2015.
  • 177 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2015.

Based on Matrix Capital Management Company's 13F filing for Q3 2015, filed 16 Nov 2015.